Responses

Download PDFPDF
Emergency management of meningococcal disease: eight years on
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Ceftriaxone drug alert - no longer for first line use in meningococcal sepsis
    • Saul N. Faust, Senior Lecturer in Paediatric Infectious Diseases
    • Other Contributors:
      • Andrew J. Pollard, Simon Nadel, Nelly Ninis, and Michael Levin

    Dear sir,

    Although UK and international high income country practice has been to recommend ceftriaxone or cefotaxime as first line therapy for the initial treatment of paediatric sepsis, the US FDA has issued an alert (1) that has led to changes in the US label for ceftriaxone (2). Due to concerns regarding the potential for calcium chelation in vivo, ceftriaxone must no longer be administered within 48 hours o...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Valuation of low blood pressure in children
    • Egidio Barbi, Medical Doctor
    • Other Contributors:
      • Laura Badina and Alessandro Ventura

    Dear Editor,

    We greatly appreciated the review by Pollard AJ. and colleagues about emergency management of meningococcal disease(1). Even though we found a questionable issue on figure 1, which report the algorithm for early management of meningococcal disease in children. In the algorithm the normal systolic blood pressure is supposed to be 80 + (age in years x 2). According to the PALS guidelines, the third...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Emergency management of meningococcal disease:eight years on

    Dear Editor,

    I read with interest the article on emergency management of meningococcal disease and welcome the publication of the revised algorithm. However I note that in the section on use of inotropes it states that adrenaline infusions must only be given by central venous route. Whilst central venous access is the gold standard, placing of a central line in paediatric patients requires skills which may not b...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Indication for tracheal intubation in meningococcal disease and septic shock
    • Martin Peter Gray, Consultant Paediatric Intensivist
    • Other Contributors:
      • Anami Gour, Caroline Davison, Jonathan Round and Linda Murdoch

    Dear Editor,

    We read with interest the recently published update to an algorithm for the early recognition and treatment of meningococcal disease in children (1). Of note there is a change to the recommended trigger point for tracheal intubation. The previously recommended trigger point has moved from after 40mls/kg of fluid resuscitation in the face of persistent shock to after 60mls/kg of fluid resuscitation. This...

    Show More
    Conflict of Interest:
    None declared.